Prognostic Significance of Survivin Expression in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP Therapy: Report from the International DLBCL Rituximab-CHOP Consortium Program

Zhiyu Liu; Zijun Y Xu-Monette; Xin Cao; Carlo Visco; Alexander Tzankov; Santiago Montes-Moreno; Karen Dybkær; April Chiu; Attilio Orazi; Youli Zu; Govind Bhagat; Kristy L Richards; Eric D. Hsi; William W.L. Choi; J Han van Krieken; Jooryung Huh; Weiyun Ai; Maurilio Ponzoni; Andrés J M Ferreri; John P Farnen; Michael B. Møller; Jane N. Winter; Miguel A Piris; L Jeffrey Medeiros; Ken H Young

doi:10.1016/j.clml.2015.04.087

Prognostic Significance of Survivin Expression in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP Therapy: Report from the International DLBCL Rituximab-CHOP Consortium Program

Zhiyu Liu
, Zijun Y Xu-Monette
, Xin Cao
, Carlo Visco
, Alexander Tzankov
, Santiago Montes-Moreno
, Karen Dybkær
, April Chiu
, Attilio Orazi
, Youli Zu
, Govind Bhagat
, Kristy L Richards
, Eric D. Hsi
, William W.L. Choi
, J Han van Krieken
, Jooryung Huh
, Weiyun Ai
, Maurilio Ponzoni
, Andrés J M Ferreri
, John P Farnen

Michael B. Møller, Jane N. Winter, Miguel A Piris, L Jeffrey Medeiros, Ken H Young

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Artikelnummer	502
Tidsskrift	Clinical Lymphoma, Myeloma & Leukemia
Vol/bind	15
Udgave nummer	Suppl. 1
Sider (fra-til)	S216
Antal sider	1
ISSN	2152-2650
DOI	https://doi.org/10.1016/j.clml.2015.04.087
Status	Udgivet - 2015
Begivenhed	Annual Meeting of the Society of Hematologic Oncology - Houston, USA Varighed: 17 sep. 2014 → 20 sep. 2014 Konferencens nummer: 2

Konference

Konference	Annual Meeting of the Society of Hematologic Oncology
Nummer	2
Land/Område	USA
By	Houston
Periode	17/09/2014 → 20/09/2014

Adgang til dokumentet

10.1016/j.clml.2015.04.087

http://www.sciencedirect.com/science/article/pii/S2152265015002451

AUB Link

Søg efter materialet i Aalborg Universitetsbiblioteks søgemaskine

Citationsformater

Liu, Z., Xu-Monette, Z. Y., Cao, X., Visco, C., Tzankov, A., Montes-Moreno, S., Dybkær, K., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Richards, K. L., Hsi, E. D., Choi, W. W. L., Han van Krieken, J., Huh, J., Ai, W., Ponzoni, M., Ferreri, A. J. M., ... Young, K. H. (2015). Prognostic Significance of Survivin Expression in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP Therapy: Report from the International DLBCL Rituximab-CHOP Consortium Program. Clinical Lymphoma, Myeloma & Leukemia, 15(Suppl. 1), S216. Artikel 502. https://doi.org/10.1016/j.clml.2015.04.087

@article{51ceb73ef9824651ab0b81900a0236d0,

title = "Prognostic Significance of Survivin Expression in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP Therapy: Report from the International DLBCL Rituximab-CHOP Consortium Program",

author = "Zhiyu Liu and Xu-Monette, \{Zijun Y\} and Xin Cao and Carlo Visco and Alexander Tzankov and Santiago Montes-Moreno and Karen Dybk{\ae}r and April Chiu and Attilio Orazi and Youli Zu and Govind Bhagat and Richards, \{Kristy L\} and Hsi, \{Eric D.\} and Choi, \{William W.L.\} and \{Han van Krieken\}, J and Jooryung Huh and Weiyun Ai and Maurilio Ponzoni and Ferreri, \{Andr{\'e}s J M\} and Farnen, \{John P\} and M{\o}ller, \{Michael B.\} and Winter, \{Jane N.\} and Piris, \{Miguel A\} and Medeiros, \{L Jeffrey\} and Young, \{Ken H\}",

year = "2015",

doi = "10.1016/j.clml.2015.04.087",

language = "English",

volume = "15",

pages = "S216",

journal = "Clinical Lymphoma, Myeloma \& Leukemia",

issn = "2152-2650",

publisher = "Elsevier",

number = "Suppl. 1",

note = "Annual Meeting of the Society of Hematologic Oncology ; Conference date: 17-09-2014 Through 20-09-2014",

}

Liu, Z, Xu-Monette, ZY, Cao, X, Visco, C, Tzankov, A, Montes-Moreno, S, Dybkær, K, Chiu, A, Orazi, A, Zu, Y, Bhagat, G, Richards, KL, Hsi, ED, Choi, WWL, Han van Krieken, J, Huh, J, Ai, W, Ponzoni, M, Ferreri, AJM, Farnen, JP, Møller, MB, Winter, JN, Piris, MA, Medeiros, LJ & Young, KH 2015, 'Prognostic Significance of Survivin Expression in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP Therapy: Report from the International DLBCL Rituximab-CHOP Consortium Program', Clinical Lymphoma, Myeloma & Leukemia, bind 15, nr. Suppl. 1, 502, s. S216. https://doi.org/10.1016/j.clml.2015.04.087

Prognostic Significance of Survivin Expression in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP Therapy: Report from the International DLBCL Rituximab-CHOP Consortium Program. / Liu, Zhiyu; Xu-Monette, Zijun Y; Cao, Xin et al.
I: Clinical Lymphoma, Myeloma & Leukemia, Bind 15, Nr. Suppl. 1, 502, 2015, s. S216.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

TY - ABST

T1 - Prognostic Significance of Survivin Expression in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP Therapy

T2 - Annual Meeting of the Society of Hematologic Oncology

AU - Liu, Zhiyu

AU - Xu-Monette, Zijun Y

AU - Cao, Xin

AU - Visco, Carlo

AU - Tzankov, Alexander

AU - Montes-Moreno, Santiago

AU - Dybkær, Karen

AU - Chiu, April

AU - Orazi, Attilio

AU - Zu, Youli

AU - Bhagat, Govind

AU - Richards, Kristy L

AU - Hsi, Eric D.

AU - Choi, William W.L.

AU - Han van Krieken, J

AU - Huh, Jooryung

AU - Ai, Weiyun

AU - Ponzoni, Maurilio

AU - Ferreri, Andrés J M

AU - Farnen, John P

AU - Møller, Michael B.

AU - Winter, Jane N.

AU - Piris, Miguel A

AU - Medeiros, L Jeffrey

AU - Young, Ken H

N1 - Conference code: 2

PY - 2015

Y1 - 2015

U2 - 10.1016/j.clml.2015.04.087

DO - 10.1016/j.clml.2015.04.087

M3 - Conference abstract in journal

SN - 2152-2650

VL - 15

SP - S216

JO - Clinical Lymphoma, Myeloma & Leukemia

JF - Clinical Lymphoma, Myeloma & Leukemia

IS - Suppl. 1

M1 - 502

Y2 - 17 September 2014 through 20 September 2014

ER -